Kymab
0 followers
Kymab is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform ava... Read more
Org chart
Simon Sturge
CEO
Simon Sturge
Collapse
Allan Bradley
Chief Scientific Officer
Anne Hyland
CFO
Nigel Clark
SVP, Business Development
Jasper Clube
SVP, Intellectual Property & Chief Patent Counsel
David Melvin
VP of Informatics
Stephen Reece
Head of IDV
Richard Williams
Vice President CMC
Teams
View all
